Skip to content

Clinicians › Knee

Periprosthetic joint infection (knee)

117 citationsUpdated Sep 2026

Overview

Periprosthetic joint infection (PJI) is a severe complication of total knee arthroplasty that generates high costs for public health systems [23]. Patient factors remain the most important predictors of early prosthetic joint infection [3], with a history of treated septic arthritis conferring high risk, particularly in knee arthroplasty compared to hip arthroplasty [1]. Wound complications after total knee arthroplasty increase the risk of deep infection, as well as cost, length of hospitalization, and readmission rates [70]. Polymicrobial infections represent a substantial proportion of all PJI occurrences [27].

Diagnosis and treatment approaches vary globally due to logistical constraints and resource availability [11]. The International Consensus on Periprosthetic Joint Infections has focused the community and should lead to better research and outcomes [2], successfully reaching agreement on all but four of 207 questions regarding prevention, diagnosis, and treatment [10]. All patients undergoing revision arthroplasty should be investigated for PJI [9]. Early-postoperative and late-chronic PJI might require different thresholds for serological markers [71].

In North America, two-stage revision arthroplasty is the treatment of choice for chronic PJI of the hip and knee [6]. Operative débridement remains the single most important treatment for infection at the site of a knee prosthesis [8]. Debridement, antibiotics, and implant retention (DAIR) is a viable and safe option when performed early after primary surgery with a relevant postrevision antibiotic regime [66]. The success of prosthesis salvage for infections occurring within 28 days after arthroplasty depends on the location, extent, and microbiology of the infection [25]. No substantial improvement in treatment success rates was detected over the 17 years examined [7]. Salvage of an infection-free prosthetic knee was achieved in only about two thirds of cases following prior staged reimplantation for septic total knee arthroplasty [5]. Polymicrobial PJI was associated with a poor outcome and a higher likelihood of requiring salvage operation when compared with monomicrobial and culture-negative infections [13], although polymicrobial prosthetic joint infections have a relatively favorable outcome, especially when treated with two-stage exchange [27]. A review failed to identify a significant difference in the ability of static or articulating spacers to eradicate PJI following total knee arthroplasty [15]. For high-risk candidates, articulating spacers can preserve knee function, reduce morbidity from second-stage surgery, and lower the costs with similar rates of infection clearance as 2-stage exchange [38]. Survivorship free from persistent PJI at 1 year is 76% in unicompartmental knee arthroplasty [19]. Patients who have been successfully managed for PJI show improvement in generic and joint-specific patient-reported outcome measures compared to their preprimary total joint arthroplasty scores [68]. Patients presenting with prosthetic joint infection from an outside institution were more likely to undergo implant resection compared to those with an index arthroplasty at the investigating institution [72]. The management of PJI in the future may still be challenging, with numerous problems to resolve and scope for plenty of research [4].

Anatomy & Pathophysiology

Osseous Anatomy

The knee joint comprises the distal femur, proximal tibia, and patella [40]. The medial femoral condyle is larger and projects farther posteriorly and distally than the lateral condyle [80]. Conversely, the lateral femoral condyle projects farther anteriorly and is wider in the medial-lateral direction than the medial condyle [80]. The tibial articular surface slopes 7° to 10° in the sagittal plane [80], with the posterior slope of the medial tibial plateau averaging 10.7° and the lateral plateau averaging 7.2° [85]. The patella is the largest sesamoid bone in the body, with a mean thickness of 2.5 cm [80, 85]. Its articular surface features a vertical central ridge separating the broader lateral facet from the medial facet, along with a smaller medial facet known as the odd facet [80]. The fibular head is located a mean of 1.5 cm distal to the joint line [85].

Ligamentous Anatomy

The anterior cruciate ligament (ACL) prevents anterior translation and rotation of the tibia on the femur [40], while the posterior cruciate ligament (PCL) prevents posterior subluxation of the tibia on the femur [40]. The medial collateral ligament stabilizes the knee against valgus stresses [40], and the lateral collateral ligament serves as the main stabilizer against varus stress [40]. The ACL is composed of 90% type I collagen and 10% type III collagen [80, 85]. It has a mean length of 33 mm and a mean midsubstance width of 11 mm [80, 85]. The PCL has a mean length of 38 mm and a mean width of 13 mm [85, 93]. As the largest intra-articular ligament, the PCL has a cross-sectional area approximately 120% to 150% greater than that of the ACL [93]. The PCL consists of two distinct bundles defined by their femoral insertion: an anterolateral (AL) bundle and a posteromedial (PM) bundle [93]. The AL bundle is larger, comprising 85% of the PCL's cross-sectional area [93].

The ACL femoral attachment is a semicircular area on the posteromedial aspect of the lateral femoral condyle [80, 85]. The ACL tibial attachment is a broad, irregular, oval-shaped area between the medial and lateral tibial spinous processes [80, 85]. The PCL inserts onto a midline depression on the tibia 10 to 15 mm below the level of the medial and lateral tibial plateaus [85, 93]. The middle geniculate artery provides the primary blood supply to both the ACL and PCL [80, 85], while the posterior articular branch of the posterior tibial nerve innervates both ligaments [85]. Biomechanically, the anteromedial bundle of the ACL is tight in knee flexion, and the posterolateral bundle is tight in knee extension [85]. Similarly, the AL bundle of the PCL is tight in knee flexion, and the PM bundle is tight in knee extension [85]. Meniscofemoral ligaments are present in 93% of knees, with both ligaments present in 70% [85, 93]. These ligaments connect the posterior horn of the lateral meniscus to the intercondylar notch [93].

Meniscal Anatomy

The menisci are C-shaped fibrocartilaginous disks that provide shock absorption, increase congruency between joint surfaces, enhance joint stability, and aid in the distribution of synovial fluid [40]. The medial meniscus is firmly attached to the joint capsule along its entire peripheral edge [40]. In contrast, the lateral meniscus is attached to the anterior and posterior capsule but has a region posterolaterally where it is not firmly attached [40]. Consequently, the medial meniscus has less mobility than the lateral meniscus and is more susceptible to tearing when trapped between the femoral condyle and tibial plateau [40]. The lateral meniscus is larger than the medial meniscus and carries a greater share of the lateral compartment pressure [40]. Structurally, the menisci consist of type I collagen fibers arranged obliquely, radially, and vertically [85]. Vascular supply is derived from the geniculate arteries, which penetrate into 20% to 30% of the peripheral medial meniscus and 10% to 25% of the peripheral lateral meniscus [85]. Morphologically, the medial meniscus is crescent-shaped and attaches more anterior and posterior [85]. The lateral meniscus is circular in shape and covers a larger proportion of the tibial plateau [85].

Vascular and Neural Anatomy

The blood supply to the knee forms an anastomosis around the joint derived from the descending geniculate artery, medial and lateral superior geniculate arteries, medial and lateral inferior geniculate arteries, middle geniculate artery, and anterior tibial recurrent arteries [80]. The knee is innervated by branches of the femoral nerve (L2, L3, L4), obturator nerve (L2, L3, L4), and sciatic nerve (L4, L5, S1, S2) [80]. The posterior articular branch of the tibial nerve is the largest nerve providing innervation to the intra-articular knee [80]. The popliteus artery travels through the adductor hiatus, where it is relatively immobile, and distally through the fibrous arch deep to the soleus muscle [90]. The common peroneal nerve travels along the posterior edge of the biceps femoris and continues distally around the fibular neck [90].

Kinematics and Biomechanics

The knee is a hinge joint that incorporates both gliding and rolling, which are essential to its kinematics [81, 82]. The "screw-home" mechanism involves the tibia externally rotating 5 degrees in the final 15 degrees of extension [81, 82]. The greatest range of motion occurs in the sagittal plane at approximately 160° [97]. Knee rotation ranges from 45° in external rotation to 30° in internal rotation [97]. The normal instant center of the knee joint follows a semicircular path related to the tibiofemoral surface and ligaments crossing the joint [97]. Rupture of the cruciate ligaments or disruption of the tibiofemoral surface causes a major change in the path of the instant center, leading to articular dysfunction [97]. In full extension, the knee slightly hyperextends with slight tibial external rotation while collateral and cruciate ligaments are tightened to lock the knee in extension [98]. The popliteus muscle initiates flexion by pulling the lateral femoral condyle backward while the medial femoral condyle slides forward, resulting in tibial internal rotation [98].

Pathophysiology of Infection

Patients with a history of treated septic arthritis are at high risk of developing periprosthetic joint infection after total joint arthroplasty, with the risk appearing greater in knee arthroplasty compared to hip arthroplasty [1]. Patient factors remain the most important in predicting early prosthetic joint infection following total knee arthroplasty [3, 172]. Greater knee soft tissue thickness predisposes patients to subsequent periprosthetic joint infection after total knee arthroplasty [39]. Therefore, soft tissue depth around the knee should be considered in all patients undergoing primary total knee arthroplasty, even in those with lower body mass index [39]. Periprosthetic joint infections occur in 1%-2% of primary total hip and knee arthroplasty cases, with an increased prevalence in revision arthroplasty cases [73]. The management of periprosthetic joint infection remains difficult primarily due to the evolution of resistance by the infecting organisms [73].

The nature of biofilm varies depending on the type of device and anatomic location, and its dynamic life cycle necessitates complex interdisciplinary studies [21]. The biofilm paradigm is different from the planktonic paradigm in all of the five H’s (Who, What, When, Where and How) [21]. The exact mechanism by which joint contamination becomes an infection is still poorly understood [159]. However, Neutrophil Extracellular Trap-related biomarkers are increased in the synovial fluid of patients with periprosthetic joint infections [159]. Synovial fluid analysis is adequate in differentiating patients with periprosthetic hip and knee infections [24]. There are differences in cell count cutoff levels between knees and hips, suggesting international guidelines and diagnostic criteria need revisions [161]. In the absence of definitive X-ray findings, synovial fluid analysis offers a promising diagnostic modality for aseptic loosening following cemented total knee arthroplasty [190]. The cellular pathophysiology of aseptic TKA complications can be used to aid in clarifying the diagnosis of aseptic loosening versus instability [75].

Classification

Periprosthetic joint infections are classified into four types based on duration and the interval from the index procedure [48]. A classification system popularised by Tsukayama in the 1990s divides periprosthetic joint infections into four categories based on the time elapsed since the operation and the preoperative status [113].

Early Postoperative: These infections present within 4 weeks of the index procedure and are usually seeded intraoperatively, though they can also be caused by hematogenous spread [48].

Acute Hematogenous: This type is characterized by an acute presentation in a previously well-functioning joint arthroplasty and may be associated with a documented or suspected bacteremia [48].

Late Chronic: These infections present indolently 1 month or more after the index arthroplasty and are usually low-grade infections thought to originate perioperatively [48]. This category includes missed acute infections (early postoperative or hematogenous) that are now greater than 4 weeks in duration [48].

Intraoperative Cultures: A final classification group includes patients with positive intraoperative cultures found at the time of revision for presumed aseptic failure [48].

Other Considerations: Infections associated with prosthetic joints can be categorized into three groups: early infections (occurring within three months after surgery), delayed infections (appearing between three and 24 months after surgery), and late infections (emerging more than 24 months after surgery) [113]. A staging system for periprosthetic infections incorporates the infection classification system with the status of the host, including both systemic and local compromising factors [48]. The Musculoskeletal Infection Society criteria are used for the diagnosis of periprosthetic joint infection, with major criteria including a communicating sinus tract and two positive cultures with the same organism [140]. The Musculoskeletal Infection Society criteria include minor criteria, where meeting at least four of six minor criteria contributes to the diagnosis [140]. The JS-BACH classification predicts outcome in periprosthetic joint infections based on joint-specific bone involvement, antimicrobial options, coverage of the soft tissues, and host status [142]. The KLIC score is a predictor of treatment response in acute prosthetic joint infection and is a useful tool in multidisciplinary treatment in hospitals that are not prosthetic joint infection reference centres [62]. The AAOS work group proposed an algorithm for diagnosing periprosthetic joint infection based on available evidence for diagnostic modalities [18]. The International Consensus on Periprosthetic Joint Infection reached agreement on all but four of 207 questions regarding the prevention, diagnosis, and treatment of periprosthetic joint infection [10].

Clinical Presentation

Brucella periprosthetic joint infections in total knee arthroplasty typically present late with nonspecific symptoms, often mimicking aseptic loosening or culture-negative periprosthetic joint infections [20]. A sinus tract serves as a major criterion for the diagnosis of periprosthetic joint infection [31]. The diagnosis relies on converging information from clinical, laboratory, and imaging assessments [31]. No single test has demonstrated absolute accuracy for the diagnosis of periprosthetic joint infection [53]. Consequently, physicians rely on a combination of serological tests, synovial markers, and clinical findings plus clinical judgment to help guide preoperative decision-making [53]. Synovial fluid aspiration, diagnostic imaging, traditional culture, peripheral serum inflammatory markers, and intraoperative frozen sections each have their limitations but continue to be the mainstay for diagnosis [59].

Laboratory Markers: Approximately 4% of patients with periprosthetic joint infection present with normal ESR and CRP [45]. Traditional laboratory markers hold low diagnostic utility for immunosuppressed patients with periprosthetic joint infections [16]. Atypical prosthetic joint infection should be considered in painful total knee arthroplasty with negative cultures and equivocal laboratory results [17]. Understanding how the accuracy of diagnostic tests varies with respect to demographic factors can help physicians avoid subjecting patients to unnecessary additional testing and reach more accurate diagnoses [55].

Synovial Fluid Analysis: Leukocyte esterase is an accurate and effective synovial fluid marker for diagnosing periprosthetic joint infection and should be used in conjunction with the current battery of available diagnostic tests [60]. The specificity of the leukocyte esterase test was found to be 99.3% in a study of 149 patients with total knee arthroplasty [43]. Synovial fluid alpha-defensin can provide an additional data point to assist the clinician in determining whether periprosthetic joint infection is present in patients with equivocal diagnosis due to recent antibiotic use, equivocal laboratory findings, or suspected false-negative or false-positive cultures [117]. However, synovial fluid alpha-defensin is prone to false-positive results in the challenging population of patients with equivocal diagnosis of periprosthetic joint infection [117]. The synovial fluid biomarker IL-6 is recommended for the diagnosis of periprosthetic joint infection following total hip and knee arthroplasty [56]. MicroRNA biomarkers offer sensitive and specific pathogen-independent biomarkers with potential clinical applications in the diagnosis of hip and knee periprosthetic joint infection [52]. D-dimer shows high sensitivity for periprosthetic joint infection diagnosis in cases of low-virulence organisms which might be missed by most diagnostic tests [121].

Microbiological Considerations: Pathogens causing periprosthetic infection in both culture-positive and culture-negative samples of synovial fluid could be identified by next-generation sequencing [124]. The pathogen spectra of periprosthetic and native joint infections differ considerably [63]. Polymicrobial periprosthetic joint infection was associated with a poor outcome when compared with monomicrobial and culture-negative infections, with patients being more likely to require a salvage operation [13].

Management Implications: Patients with suspected late periprosthetic joint infection should not receive antibiotics until the diagnosis is reached or refuted [122]. The AAOS work group recommends against initiating antibiotics before cultures are obtained and against using intraoperative Gram stain to rule out periprosthetic joint infection [18]. Diagnostic criteria and treatment approaches for periprosthetic joint infection vary globally due to logistical constraints and resource availability, hindering comparative research [11].

Investigations

Diagnostic Criteria and Algorithms: The diagnosis of peri-prosthetic bone and joint infections relies on converging information from clinical, laboratory, and imaging assessments, with clinical findings such as a sinus tract serving as major criteria [31]. No single test has demonstrated absolute accuracy for the diagnosis of periprosthetic joint infection (PJI); physicians rely on a combination of serological tests, synovial markers, and clinical findings plus clinical judgment to help guide preoperative decision-making [53]. A validated, evidence-based algorithm for diagnosing PJI should guide clinicians in the workup of patients undergoing revision arthroplasty [157].

Aspiration: Leukocyte esterase (LE) is an accurate and effective synovial fluid marker for diagnosing periprosthetic joint infection and should be used in conjunction with the current battery of available diagnostic tests [60]. In a study of 200 patients undergoing total knee arthroplasty, the specificity of the leukocyte esterase test was found to be 99.3% [43]. The use of the synovial fluid biomarker IL-6 is recommended for the diagnosis of periprosthetic joint infection following total hip and knee arthroplasty [56]. The authors recommend against the routine use of synovial alpha-defensin and suggest it be reserved for cases where PJI cannot be diagnosed or ruled out with standard testing [57]. Synovial fluid microRNA biomarkers offer sensitive and specific pathogen-independent biomarkers with potential clinical applications in the diagnosis of hip and knee periprosthetic joint infection [52]. The study provides insight into the cellular pathophysiology of aseptic TKA complications and can be used to aid in clarifying the diagnosis of aseptic loosening versus instability [75]. Sonication is an evolving modality in the context of periprosthetic joint infections [174].

Laboratory: Interleukin-6 (IL-6) in serum and in synovial fluid enhances the differentiation between periprosthetic joint infection and aseptic loosening [56]. Variation in inflammatory biomarkers among demographic groups significantly affects their accuracy in diagnosing periprosthetic joint infection [55]. The change in serum Interleukin-6 between stages does not appear to identify subsequent PJI in patients who have two-stage revision for periprosthetic joint infection [79]. The study identified two intra-articular CRP cut-offs of potential usefulness for diagnosing knee prosthesis infection [173]. More accurate diagnostic tools are needed to support clinical judgment in monitoring infection progress and thus deciding whether or not to proceed with TKA reimplantation [171]. Further investigation of diagnostic tests following staged treatment of PJI is needed [165]. Further studies are needed to explore diagnostic tests that will better detect PJI in patients with inflammatory arthritis [167].

CT: CT imaging in the axial, sagittal, and coronal planes may help visualize osteolytic lesions around joint arthroplasty and cortical disruption in cases of infection or neoplasia [42].

Bone scan: Gallium-67 (Ga-67) is a radionuclide that may help differentiate between aseptic and septic prosthetic loosening; 24 to 72 hours are needed for a complete study [42].

Plain radiography: A high index of suspicion may result from careful examination of plain radiographs, and further imaging studies, including CT or MRI, are essential for diagnosis of septic knee arthritis with adjacent chronic osteomyelitis [147].

Other Considerations: We recommend that all patients undergoing revision arthroplasty be investigated for periprosthetic joint infection [9]. Brucella PJIs in a TKA typically present late with nonspecific symptoms, often mimicking aseptic loosening or culture-negative PJIs [20]. This case report demonstrates the importance of considering atypical prosthetic joint infection in painful total knee arthroplasty with negative cultures and equivocal laboratory results [17].

Treatment

General Principles

The International Consensus on Periprosthetic Joint Infections has focused the community and should lead to better research and outcomes, though many areas still require further research [2]. Despite increasing clinical focus and research advances, no substantial improvement in treatment success rates for periprosthetic joint infection was detected over the 17 years examined [7]. The BOOM meeting achieved consensus for important topics on periprosthetic infection in orthopaedic oncology, but highlighted the low quality of the underlying evidence [37].

Debridement, Antibiotics, and Implant Retention (DAIR)

Indications: DAIR is recommended as a choice for patients with current infection within 12 weeks after primary TKA [146]. It is a viable and safe treatment option for PJI following primary TKA surgery when performed early after primary surgery and with the addition of a relevant postrevision antibiotic regime [66]. Success of prosthesis salvage for periprosthetic infections occurring within 28 days after arthroplasty depends on the location, extent, and microbiology of the infection [25]. In a prospective multicenter study of 189 cases, time since primary total knee arthroplasty was a key predictor of DAIR success, with success highest in infections occurring within 1 month and progressively decreasing as time increased [28]. Late infections had a high failure rate of DAIR irrespective of their classification as hematogenous or chronic [28].

Outcomes and Limitations: In a retrospective review of 104 patients, irrigation and debridement was successful in 46 patients (44%), with staphylococcal infection, elevated American Society of Anesthesiologists score, and purulence around the prosthesis being more likely to fail [114]. The high failure rate of irrigation and debridement implies that it should be preferably limited to select healthy patients with low virulence organisms and equivocal intraoperative findings [114]. Surgeons should be cautious using irrigation and debridement as a routine means to address periprosthetic joint infection [145]. The treatment failed to eradicate the infection in 16 cases (84% failure rate), with a total success rate of open debridement and component retention in acute periprosthetic MRSA knee infection of 18% when combined with literature review [35]. Given that persistent infection was most common in knees and Staphylococcus aureus, irrigation and debridement should have a limited role in treating periprosthetic joint infection, especially in these cases [61]. Survivorship free from persistent PJI at 1 year is low at 76% for unicompartmental knee arthroplasty treated with DAIR, which is consistent with similar reports for total knee arthroplasties [19].

Surgical Strategy: The probability of treatment failure (removal of implants) was not significantly different between patients treated with single versus multiple irrigation and debridements [54]. The interval between serial irrigation and debridements was a significant factor determining outcomes in patients treated with multiple procedures [54]. Patients treated with multiple irrigation and debridements had a significantly higher prevalence of peripheral vascular disease [54].

Two-Stage Revision

Outcomes: Salvage of an infection-free prosthetic knee was achieved in only about two thirds of the cases following prior staged reimplantation [5]. A favorable outcome in patients with PJI undergoing a 2-stage procedure was associated with an infection sustained by Gram-positive bacteria, absence of known comorbidities, and administration of oral therapy [36]. The results support the effectiveness of a 2-stage reimplantation protocol with a standard 1:8 minimal bactericidal titer for treating infections after TKA, including multidrug-resistant organisms [143]. Consistent infection eradication was found at a 1-year follow-up with a short-interval two-stage approach to primary total knee arthroplasty for acutely septic osteoarthritic knees, with postoperative range of motion and knee scores comparing favourably with other case series [22].

Technique and Spacers: Two-stage revision of septic knee prosthesis with articulating knee spacers yields better infection eradication rate than one-stage or two-stage revision with static spacers [51]. Prerevision cultures, grown after discontinuation of antibiotic treatment and before reimplantation of the components, helped to identify patients with infection at the site of a total knee arthroplasty in whom the infection might recur [78]. Outcomes after prosthesis removal and antibiotic spacer placement are variable, and there are several independent risk factors for such outcomes that may be used to develop and improve existing treatment strategies for patients presenting with chronic PJI after TKA [148]. This study highlights the challenge of treating infected knee arthroplasties in physiologically compromised patients with 9/13 (69%) having satisfactory clinical outcomes [12].

One-Stage Revision

Data provide preliminary support to the use of a single-stage approach in highly selected patients with chronically infected TKAs as an alternative to a two-stage procedure [166]. With an overall revision rate of about 25% at 6 years and limited functional results based on poor Oxford Knee Scores, patients should be counseled to have modest expectations concerning postoperative pain and function for infected rotating-hinge implants treated with one-stage-exchange [29].

Spacer Management

Treatment of patients with an infected total knee arthroplasty with high-dose vancomycin and gentamicin antibiotic spacers seems to be clinically safe [127]. Use of an articulating spacer achieved soft tissue compliance, allowed for ease of operation, reduced postoperative pain, improved function, and eradicated infection equal to standards reported in the literature [116]. The practice patterns of American Association of Hip and Knee Surgeons members show a preference toward performing a two-stage exchange arthroplasty with an articulating spacer using a metal femoral component and an all-polyethylene liner [120].

Antibiotic Therapy

Rifampin combination therapy in staphylococcal prosthetic joint infections was evaluated in a randomized controlled trial [112]. The role of long-term antibiotic suppression in the management of peri-prosthetic joint infections treated with debridement, antibiotics, and implant retention was evaluated in a systematic review [119].

Prevention and Prophylaxis

Routine prophylactic use of antibiotic-laden bone cement in primary total knee arthroplasty has not led to changes in infecting pathogen profile, nor has it led to the emergence of antimicrobial resistance at this institution [26]. The use of vancomycin as the perioperative prophylactic antibiotic for primary total joint arthroplasties appeared to be effective in decreasing the rate of PJI and may result, when they occur, in infections with less virulent organisms [128]. Administration of intrawound vancomycin powder has no efficacy in preventing periprosthetic joint infection in primary total knee arthroplasty [138]. The intrawound application of vancomycin powder was demonstrated to be inferior to standard postoperative IV antibiotics in reducing the incidence of periprosthetic joint infections after total knee arthroplasty [139].

Specific Pathogens and Patient Factors

Soft tissue depth around the knee should be considered in all patients undergoing primary total knee arthroplasty, even in those with lower body mass index, as greater soft tissue thickness predisposes patients to subsequent periprosthetic joint infection [39]. Orthopaedic surgeons should strongly consider patient comorbidities when selecting treatment pathways for PJIs [149].

Complications

Infection (PJI): Periprosthetic joint infection risk is elevated in patients with a history of treated septic arthritis, particularly in knee arthroplasty compared to hip arthroplasty [1]. Prior cellulitis, especially within one year of surgery, also predisposes to infection [162]. Polymicrobial infections carry a poorer prognosis than monomicrobial or culture-negative cases [13]. Methicillin-resistant organisms are associated with a 3.37-fold increased likelihood of failed two-stage exchange arthroplasty [77]. Favorable outcomes in two-stage procedures correlate with Gram-positive pathogens, the absence of known comorbidities, and the administration of oral therapy [36]. Atypical pathogens, such as Mycobacterium kansasii, must be considered in painful knees with negative cultures and equivocal laboratory results [17].

Treatment Outcomes and Failure Rates: Failure rates remain high after revision for PJI, with significant risk of failure at one-year follow-up [50]. High pathogen persistence and low survival time to recurrence necessitate close monitoring within two years [74]. In significantly compromised (host-C) patients, 9/13 (69%) achieved satisfactory clinical outcomes following two-stage revision [12]. Open debridement and component retention for acute methicillin-resistant Staphylococcus aureus infections resulted in an 84% failure rate (16 cases) [35], with a total success rate of 18% when combined with literature review data [35]. For unicompartmental knee arthroplasty treated with debridement, antibiotics, and implant retention, survivorship free from persistent infection at one year is 76% [19]. The probability of treatment failure via implant removal was not significantly different between single irrigation and debridement and additional procedures, though the interval between serial debridements significantly determined outcomes [54]. A short-interval two-stage approach for acutely septic osteoarthritic knees yielded consistent infection eradication at one year and favorable postoperative range of motion and knee scores compared to other case series [22]. Hematogenous infection after successful two-stage exchange is a rare but critical cause of reinfection [169].

Salvage and Alternative Procedures: Arthrodesis using a silver-coated intramedullary device successfully eradicates infection and allows limb conservation in unsalvageable infected total knee arthroplasties [130]. In a retrospective analysis of eight patients, there were no amputations, deaths, or implant revisions at follow-up [130]. One case of recurrent infection was successfully managed with washout and debridement [130]. The mean difference in Oxford Knee Score between pre- and post-arthrodesis was 8.9 points (P .086) [130]. Pain, night pain, and ease of standing showed significant improvement following silver-coated arthrodesis (P .019, P .021, and P .003, respectively) [130].

Wound Complications: Wound complications after total knee arthroplasty increase cost, length of hospitalization, readmission rates, and the risk of deep infection [70]. Intrawound vancomycin administration does not decrease PJI occurrence but significantly causes aseptic wound complications in primary total knee arthroplasty [152]. Routine prophylactic use of antibiotic-laden bone cement has not altered the infecting pathogen profile or led to the emergence of antimicrobial resistance at the reporting institution [26].

Other Considerations: The prevalence of multiple periprosthetic joint infections has decreased compared to historical reports, likely due to higher rates of two-stage revisions and fewer patients treated with irrigation and debridement [34]. Concomitant multiple periprosthetic joint infections are rare events that most often result from secondary hematogenous spread from a distant infectious focus [133].

Recovery

Light activity (weeks): The provided evidence does not specify a typical week range for desk work, driving, or light activities of daily living.

Full activity (months): The provided evidence does not specify a month range for manual work, sport, or full range-of-motion and strength return.

Complete recovery / outcome plateau (months): The provided evidence does not specify a month range for the stabilization of pain, strength, or final functional outcomes.

Rehabilitation protocol: The provided evidence does not detail specific physical therapy phasing, immobilisation duration, weight-bearing progression, or brace removal timing.

Functional milestones: Postoperative range of motion and knee scores for the short-interval two-stage approach to primary total knee arthroplasty for acutely septic osteoarthritic knees compare favourably with those of other case series [22]. Two-stage re-implantation with an articulating spacer for infected total knee arthroplasty effectively treats infection and provides excellent knee motion between stages, as well as at mid- to long-term follow-up [155]. Rotating hinge total knee arthroplasty using a single modular implant demonstrates acceptable survival rates and function compared to previous studies [76].

Other Considerations: Prognosis is influenced by specific patient factors and pathogen types. The risk of periprosthetic joint infection after total joint arthroplasty appears greater in knee arthroplasty compared to hip arthroplasty for patients with a history of treated septic arthritis [1]. In patients with neuropathic (Charcot) arthropathy, periprosthetic joint infection led to a 10-year survivorship free of any revision of 70% [58]. At a mean follow-up of 6.4 years, overall survival was 96.7%, with only 2.2% of patients revised due to a periprosthetic joint infection in patients with asymptomatic elevated inflammatory markers [65].

Treatment efficacy varies by procedure and organism. A favorable outcome in patients with periprosthetic joint infection undergoing a 2-stage procedure was associated with an infection sustained by Gram-positive bacteria, absence of known comorbidities, and administration of oral therapy [36]. The treatment failed to eradicate the infection in 16 cases (84% failure rate) for acute periprosthetic methicillin-resistant Staphylococcus aureus knee infection treated by open debridement and retention of components [35]. A periprosthetic joint infection eradication rate of 72% with acceptable functional outcome was described for massive endoprostheses used for managing periprosthetic joint infections of the hip and knee [69]. The prevalence of multiple periprosthetic joint infections has decreased compared with historical reports, likely due to higher rates of 2-stage revisions and fewer patients treated with irrigation and debridement [34]. The risk of developing a subsequent periprosthetic joint infection in patients with multiple arthroplasties was identified to be one half of previous studies [14].

Diagnostic monitoring presents specific challenges. Prerevision cultures, grown after discontinuation of antibiotic treatment and before reimplantation of the components, helped to identify the patients with infection at the site of a total knee arthroplasty in whom the infection might recur [78]. The change in serum interleukin-6 between stages does not appear to identify subsequent periprosthetic joint infection in patients who have two-stage revision [79]. Brucella periprosthetic joint infections in a total knee arthroplasty typically present late with nonspecific symptoms, often mimicking aseptic loosening or culture-negative periprosthetic joint infections [20].

Reinfection remains a critical failure mode. (Re-)infection is the most relevant mode of failure for rotating hinge total knee arthroplasty using a single modular implant [76]. Many areas regarding periprosthetic joint infection still require further research [2]. Continued investigation is required to determine the fate of infected joints that undergo debridement, antibiotics, and implant retention with regard to ultimate patient outcome [176].

Key Evidence

  • [L3] Patients with a history of treated septic arthritis are at high risk of developing periprosthetic joint infection after total joint arthroplasty, with the risk appearing greater in knee arthroplasty compared to hip arthroplasty. [1] (10.1097/corr.0000000000000734)
  • [L5] The International Consensus on Periprosthetic Joint Infections has focused the community and should lead to better research and outcomes, though many areas still require further research. [2] (10.1302/0301-620x.95b11.33224)
  • [L2] Patient factors remain the most important in terms of predicting early prosthetic joint infection following total knee arthroplasty. [3] (10.1302/0301-620x.98b3.36775)
  • [L5] Despite increasing recent interest, the management of periprosthetic joint infections in the future may still be challenging, with numerous problems to resolve and scope for plenty of research. [4] (10.1302/0301-620x.104b11.bjj-2022-0944)
  • [L3] Salvage of an infection-free prosthetic knee was achieved in only about two thirds of the cases. [5] (10.1016/j.arth.2010.04.017)
  • [L5] In North America, two-stage revision arthroplasty is the treatment of choice for chronic periprosthetic infection of the hip and knee. [6] (10.5435/jaaos-22-03-153)
  • [L3] Despite increasing clinical focus and research advances, no substantial improvement in treatment success rates for periprosthetic joint infection was detected over the 17 years examined. [7] (10.1016/j.arth.2020.01.080)
  • [L5] Operative débridement remains the single most important treatment for an infection at the site of a knee prosthesis. [8] (10.2106/00004623-199302000-00018)
  • [L2] We recommend that all patients undergoing revision arthroplasty be investigated for periprosthetic joint infection. [9] (10.1016/j.arth.2011.01.019)
  • [L5] The consensus process successfully reached agreement on all but four of 207 questions regarding the prevention, diagnosis, and treatment of periprosthetic joint infection, providing a comprehensive approach to minimize variations in care and reduce the burden of infection. [10] (10.1302/0301-620x.95b11.33135)
  • [L5] Diagnostic criteria and treatment approaches for periprosthetic joint infection vary globally due to logistical constraints and resource availability, hindering comparative research. [11] (10.2106/jbjs.25.00775)
  • [L4] This study highlights the challenge of treating infected knee arthroplasties in physiologically compromised patients with 9/13 (69%) having satisfactory clinical outcomes. [12] (10.1007/s00167-018-5051-y)
  • [L3] Polymicrobial periprosthetic joint infection was associated with a poor outcome when compared with monomicrobial and culture-negative infections, with patients being more likely to require a salvage operation. [13] (10.2106/jbjs.15.01450)
  • [L3] The study identified the risk of developing a subsequent periprosthetic joint infection to be one half of previous studies. [14] (10.1016/j.arth.2017.10.024)
  • [L2] Our review failed to identify a significant difference in the ability of static or articulating spacers to eradicate periprosthetic infection following total knee arthroplasty. [15] (10.2106/jbjs.l.01461)
  • [L3] Further investigation is necessary to identify the best means of diagnosing periprosthetic joint infection in this patient population. [16] (10.1016/j.arth.2019.03.013)
  • [L5] This case report demonstrates the importance of considering atypical prosthetic joint infection in painful total knee arthroplasty with negative cultures and equivocal laboratory results. [17] (10.5435/jaaosglobal-d-21-00183)
  • [L5] The AAOS work group convened to evaluate available evidence for diagnostic modalities and propose an algorithm for diagnosing periprosthetic joint infection (PJI), recommending against initiating antibiotics before cultures are obtained and against using intraoperative Gram stain to rule out PJI. [18] (10.5435/00124635-201012000-00007)
  • [L3] Survivorship free from persistent PJI at 1 year is low at 76% but is consistent with similar reports of DAIRs for total knee arthroplasties. [19] (10.1016/j.arth.2020.02.036)
  • [L3] Brucella PJIs in a TKA typically present late with nonspecific symptoms, often mimicking aseptic loosening or culture-negative PJIs. [20] (10.2106/jbjs.rvw.25.00079)
  • [L5] [21] (10.5435/jaaos-d-14-00455)
  • [L5] Consistent infection eradication was found at a 1-year follow-up with postoperative range of motion and knee scores comparing favourably with those of other case series. [22] (10.1007/s00167-016-3982-8)
  • [L4] PJIs are a severe complication of total knee arthroplasty that generates a high cost for the public health system. [23] (10.1016/j.arth.2013.02.012)
  • [L1] Synovial fluid analysis is adequate in differentiating patients with periprosthetic hip and knee infections. [24] (10.1007/s00264-018-3865-3)
  • [L4] Success of prosthesis salvage for periprosthetic infections occurring within 28 days after arthroplasty depends on the location, extent, and microbiology of the infection. [25] (10.1007/s11999-010-1291-y)
  • [L3] Routine prophylactic use of antibiotic-laden bone cement in primary total knee arthroplasty has not led to changes in infecting pathogen profile, nor has it led to the emergence of antimicrobial resistance at this institution. [26] (10.1016/j.arth.2013.12.004)
  • [L3] Polymicrobial prosthetic joint infections represent a substantial proportion of all PJI occurrences and have a relatively favorable outcome, especially when treated with two-stage exchange. [27] (10.1007/s11999-008-0230-7)
  • [L2] [28] (10.1016/j.arth.2023.04.024)
  • [L4] With an overall revision rate of about 25% at 6 years and limited functional results based on poor Oxford Knee Scores, patients should be counseled to have modest expectations concerning postoperative pain and function. [29] (10.1097/corr.0000000000001868)
  • [L4] The diagnosis of peri-prosthetic bone and joint infections relies on converging information from clinical, laboratory, and imaging assessments, with clinical findings like a sinus tract serving as major criteria. [31] (10.1016/j.otsr.2018.04.029)
  • [L4] The prevalence of multiple periprosthetic joint infections has decreased compared with historical reports, likely due to higher rates of 2-stage revisions and fewer patients treated with I&D. [34] (10.1016/j.arth.2016.05.013)
  • [L3] The treatment failed to eradicate the infection in 16 cases (84% failure rate), with a total success rate of ODCR in acute periprosthetic MRSA knee infection of 18% when combined with literature review. [35] (10.1016/j.arth.2009.04.028)
  • [L3] A favorable outcome in patients with PJI undergoing 2-stage procedure was associated with an infection sustained by Gram-positive bacteria, absence of known comorbidities, and administration of oral therapy. [36] (10.1016/j.arth.2017.02.057)
  • [L5] The BOOM meeting achieved consensus for important topics on periprosthetic infection in orthopaedic oncology, but highlighted the low quality of the underlying evidence. [37] (10.1302/0301-620x.107b12.bjj-2024-1039.r4)
  • [L3] For high-risk candidates, articulating spacers can preserve knee function, reduce morbidity from second-stage surgery, and lower the costs with similar rates of infection clearance as 2-stage exchange. [38] (10.1016/j.arth.2023.01.036)
  • [L3] Soft tissue depth around the knee should be considered in all patients undergoing primary total knee arthroplasty, even in those with lower body mass index. [39] (10.1016/j.arth.2020.02.049)
  • [L3] [43] (10.1016/j.arth.2016.05.065)
  • [L3] Approximately 4% of patients with periprosthetic joint infection present with normal ESR and CRP. [45] (10.1302/0301-620x.97b7.35500)
  • [L4] [48] (10.1007/s11999-010-1293-9)
  • [L3] The risk of failure after one-year follow-up is high after revision for periprosthetic joint infection. [50] (10.1002/ksa.12762)
  • [L4] [51] (10.1007/s00167-012-1885-x)
  • [L2] These miRNAs offer sensitive and specific pathogen-independent biomarkers with potential clinical applications in the diagnosis of hip and knee periprosthetic joint infection. [52] (10.2106/jbjs.24.01559)
  • [L4] No single test has demonstrated absolute accuracy for the diagnosis of periprosthetic joint infection (PJI); physicians rely on a combination of serological tests, synovial markers, and clinical findings plus clinical judgment to help guide preoperative decision-making. [53] (10.2106/jbjs.23.00669)
  • [L3] [54] (10.1016/j.arth.2015.06.051)
  • [L3] Understanding how the accuracy of diagnostic tests varies with respect to demographic factors can help physicians avoid subjecting patients to unnecessary additional testing and reach more accurate diagnoses of PJI. [55] (10.1016/j.arth.2020.10.036)
  • [L2] On the basis of the results we recommend the use of the synovial fluid biomarker IL-6 for the diagnosis of periprosthetic joint infection following total hip and knee arthroplasty. [56] (10.1371/journal.pone.0089045)
  • [L2] The authors recommend against its routine use and suggest it be reserved for cases where PJI cannot be diagnosed or ruled out with standard testing. [57] (10.1302/0301-620X.102B5.BJJ-2019-0473.R3)
  • [L4] While 10-year survivorship free of aseptic revision was 88%, periprosthetic joint infection led to the poorer survivorship free of any revision of 70% at 10 years. [58] (10.1016/j.arth.2018.04.003)
  • [L5] Synovial fluid aspiration, diagnostic imaging, traditional culture, peripheral serum inflammatory markers, and intraoperative frozen sections each have their limitations but continue to be the mainstay for diagnosis of periprosthetic joint infection. [59] (10.5435/jaaos-d-14-00385)
  • [L3] LE is an accurate and effective synovial fluid marker for diagnosing periprosthetic joint infection and should be used in conjunction with the current battery of available diagnostic tests. [60] (10.1016/j.arth.2017.06.005)
  • [L3] Given that persistent infection was most common in knees and Staphylococcus aureus, irrigation and debridement should have a limited role in treating periprosthetic joint infection, especially in these cases. [61] (10.1016/j.arth.2016.05.040)
  • [L3] The KLIC score is a useful tool in the multidisciplinary treatment of acute prosthetic joint infections in hospitals that are not prosthetic joint infection reference centres. [62] (10.1007/s00264-017-3670-4)
  • [L3] The pathogen spectra of periprosthetic and native joint infections differ considerably. [63] (10.1186/s13018-021-02850-3)
  • [L3] At a mean follow-up of 6.4 years, overall survival was 96.7%, with only 2.2% of patients revised due to a PJI. [65] (10.1016/j.arth.2024.10.063)
  • [L3] We find DAIR to be a viable and safe treatment option for PJI following primary TKA surgery, when performed early after primary surgery and with the addition of a relevant postrevision antibiotic regime. [66] (10.1016/j.arth.2018.09.088)
  • [L4] Patients who have been successfully managed for PJI show improvement in generic and joint-specific PROMs compared to their preprimary TJA PROMs. [68] (10.1016/j.arth.2025.02.011)
  • [L4] We describe PJI eradication rate of 72% with acceptable functional outcome. [69] (10.1016/j.arth.2017.09.046)
  • [L5] Wound complications after total knee arthroplasty increase cost, length of hospitalization, readmission rates, and the risk of deep infection; prevention is ideal through optimal patient health, careful planning, and detailed postoperative care. [70] (10.1016/j.arth.2007.03.014)
  • [L3] Early-postoperative and late-chronic PJI might require different thresholds. [71] (10.1007/s11999-013-3070-z)
  • [L3] Patients presenting with prosthetic joint infection from an outside institution were more likely to undergo implant resection compared to those with an index arthroplasty at the investigating institution. [72] (10.1016/j.arth.2018.09.091)
  • [L4] [73] (10.1016/j.arth.2017.07.045)
  • [L3] The high rate of pathogen persistence and the relatively low survival time to recurrence suggests a need to more closely monitor PJIs cases within 2 years. [74] (10.1016/j.arth.2023.04.063)
  • [L3] This study provides insight into the cellular pathophysiology of aseptic TKA complications and can be used to aid in clarifying the diagnosis of aseptic loosening versus instability. [75] (10.1016/j.arth.2024.12.017)
  • [L3] Rotating hinge total knee arthroplasty using a single modular implant shows acceptable survival rates and function compared to previous studies with (re-)infection being the most relevant mode of failure. [76] (10.1007/s00167-019-05593-1)
  • [L4] Patients who failed two-stage exchange arthroplasty were 3.37 times more likely to have been originally infected with a methicillin-resistant organism. [77] (10.1007/s11999-010-1296-6)
  • [L3] Prerevision cultures, grown after discontinuation of antibiotic treatment and before reimplantation of the components, helped to identify the patients with infection at the site of a total knee arthroplasty in whom the infection might recur. [78] (10.2106/00004623-200011000-00006)
  • [L3] Furthermore, the change in between stages does not appear to identify subsequent PJI. [79] (10.1016/j.arth.2023.06.008)
  • [L1] [112] (10.1186/s13018-020-01877-2)
  • [L1] [113] (10.1016/j.jisako.2023.09.003)
  • [L3] [114] (10.1016/j.arth.2010.01.104)
  • [L4] [116] (10.1097/01.blo.0000149241.77924.01)
  • [L4] In patients for whom the diagnosis of PJI is unclear because of recent antibiotic use, equivocal laboratory findings, or suspected false-negative or false-positive cultures, synovial fluid alpha-defensin can provide an additional data point to assist the clinician in determining whether PJI is present but is prone to false-positive results in this challenging population. [117] (10.1016/j.arth.2018.06.026)
  • [L4] [119] (10.1016/j.arth.2019.11.026)
  • [L4] [120] (10.1016/j.arth.2023.04.059)
  • [L3] However, it shows high sensitivity for PJI diagnosis in cases of low-virulence organisms which might be missed by most diagnostic tests. [121] (10.1016/j.arth.2023.05.022)
  • [L3] Patients with suspected late-PJI should not receive antibiotics until the diagnosis is reached or refuted. [122] (10.1007/s11999-015-4142-z)
  • [L2] Pathogens causing periprosthetic infection in both culture-positive and culture-negative samples of synovial fluid could be identified by next-generation sequencing. [124] (10.1302/0301-620x.100b2.bjj-2017-0531.r2)
  • [L4] Treatment of patients with an infected total knee arthroplasty with high-dose vancomycin and gentamicin antibiotic spacers seems to be clinically safe. [127] (10.1097/01.blo.0000144476.43661.10)
  • [L3] The use of vancomycin as the perioperative prophylactic antibiotic for primary total joint arthroplasties appeared to be effective in decreasing the rate of PJI and may result, when they occur, in infections with less virulent organisms. [128] (10.1016/j.arth.2012.03.040)
  • [L4] [130] (10.1016/j.arth.2016.04.009)
  • [L4] Concomitant multiple PJIs are rare events that occur most often as a result of secondary hematogenous spread from a distant infectious focus. [133] (10.1016/j.arth.2016.02.012)
  • [L3] Administration of intrawound vancomycin powder has no efficacy in preventing periprosthetic joint infection in primary total knee arthroplasty. [138] (10.1007/s00167-019-05778-8)
  • [L1] The trial demonstrated the intrawound application of vancomycin powder to be inferior to standard postoperative IV antibiotics in reducing the incidence of periprosthetic joint infections after total knee arthroplasty. [139] (10.1016/j.arth.2023.01.040)
  • [L4] [140] (10.1016/j.arth.2025.03.005)
  • [L2] [142] (10.1016/j.arth.2024.03.070)
  • [L3] The results support previous studies that demonstrated the effectiveness of a 2-stage reimplantation protocol with a standard 1:8 minimal bactericidal titer for treating infections after TKA, including multidrug-resistant organisms. [143] (10.1016/j.arth.2009.07.017)
  • [L4] Surgeons should be cautious using this procedure as a routine means to address periprosthetic joint infection. [145] (10.1007/s11999-011-1910-2)
  • [L3] We recommended DAIR as a choice for patients with current infection within 12 weeks after primary TKA. [146] (10.1186/s13018-022-03218-x)
  • [L4] A high index of suspicion may result from careful examination of plain radiographs, and further imaging studies, including CT or MRI, are essential for diagnosis of septic knee arthritis with adjacent chronic osteomyelitis. [147] (10.1007/s00167-009-0976-9)
  • [L3] Outcomes after prosthesis removal and antibiotic spacer placement are variable, and there are several independent risk factors for such outcomes that may be used to develop and improve existing treatment strategies for patients presenting with chronic PJI after TKA. [148] (10.1016/j.arth.2017.08.037)
  • [L3] Orthopaedic surgeons should strongly consider patient comorbidities when selecting treatment pathways for PJIs. [149] (10.1016/j.arth.2025.05.127)
  • [L2] Intrawound vancomycin administration does not decrease periprosthetic joint infection occurrence in primary total knee arthroplasty and significantly causes aseptic wound complications. [152] (10.1007/s00167-019-05498-z)
  • [L4] Two-stage re-implantation with an articulating spacer for infected TKA effectively treats infection and gives excellent knee motion between stages, and at mid- to long-term follow-up. [155] (10.1016/j.arth.2008.04.003)
  • [L3] This validated, evidence-based algorithm for diagnosing PJI should guide clinicians in the workup of patients undergoing revision arthroplasty and improve clinical practice. [157] (10.1016/j.arth.2019.06.016)
  • [Paper] [159] (10.1097/corr.0000000000002971)
  • [L3] However, there are differences in cutoff levels between knees and hips, suggesting international guidelines and diagnostic criteria need revisions. [161] (10.1016/j.arth.2018.05.018)
  • [L3] Prior cellulitis is a risk factor for periprosthetic joint infection after total knee arthroplasty, especially when it occurs within a year of surgery. [162] (10.1016/j.arth.2025.07.007)
  • [L3] Further investigation of this and other diagnostic tests following staged treatment of PJI is needed. [165] (10.1016/j.arth.2019.03.019)
  • [L3] Our data provide preliminary support to the use of a single-stage approach in highly selected patients with chronically infected TKAs as an alternative to a two-stage procedure. [166] (10.1007/s11999-014-3721-8)
  • [L2] Further studies are needed to explore diagnostic tests that will better detect PJI in patients with inflammatory arthritis. [167] (10.1016/j.arth.2019.01.051)
  • [L4] Hematogenous infection after a successful two-stage exchange arthroplasty is a rare but very important cause of a reinfection. [169] (10.1007/s00402-018-2972-3)
  • [L3] More accurate diagnostic tools are needed to support clinical judgment in monitoring infection progress and thus deciding whether or not to proceed with TKA reimplantation. [171] (10.1016/j.arth.2008.11.041)
  • [L3] Patient factors remain the most important in terms of predicting early PJI following TKA. [172] (10.1177/2325967116s00087)
  • [L3] The study identified two intra-articular CRP cut-offs of potential usefulness for diagnosing knee prosthesis infection. [173] (10.1016/j.otsr.2013.10.017)
  • [L1] Sonication is an evolving modality in the context of periprosthetic joint infections. [174] (10.1016/j.arth.2018.02.077)
  • [L3] Continued investigation is required to determine the fate of infected joints that undergo DAIR with regard to ultimate patient outcome. [176] (10.1097/corr.0000000000003138)
  • [L4] In the absence of definitive X-ray findings, synovial fluid analysis offers a promising diagnostic modality. [190] (10.1016/j.arth.2025.04.067)

References

[1] CORR Insights®: Patients with a History of Treated Septic Arthritis are at High Risk of Periprosthetic Joint Infection after Total Joint Arthroplasty. Clinical Orthopaedics & Related Research. 2019. DOI: 10.1097/corr.0000000000000734

[2] Is this the era of consensus?. The Bone & Joint Journal. 2013. DOI: 10.1302/0301-620x.95b11.33224

[3] The impact of patient and surgical factors on the rate of infection after primary total knee arthroplasty. The Bone & Joint Journal. 2016. DOI: 10.1302/0301-620x.98b3.36775

[4] Periprosthetic joint infection: what next?. The Bone & Joint Journal. 2022. DOI: 10.1302/0301-620x.104b11.bjj-2022-0944

[5] Reinfection After Prior Staged Reimplantation for Septic Total Knee Arthroplasty: Is Salvage Still Possible?. The Journal of Arthroplasty. 2010. DOI: 10.1016/j.arth.2010.04.017

[6] Two-stage Revision Arthroplasty for Management of Chronic Periprosthetic Hip and Knee Infection. Journal of the American Academy of Orthopaedic Surgeons. 2014. DOI: 10.5435/jaaos-22-03-153

[7] Is Treatment of Periprosthetic Joint Infection Improving Over Time?. The Journal of Arthroplasty. 2020. DOI: 10.1016/j.arth.2020.01.080

[8] Alternatives to reimplantation for salvage of the total knee arthroplasty complicated by infection.. The Journal of Bone & Joint Surgery. 1993. DOI: 10.2106/00004623-199302000-00018

[9] Revision Total Knee Arthroplasty: Infection Should Be Ruled Out in All Cases. The Journal of Arthroplasty. 2012. DOI: 10.1016/j.arth.2011.01.019

[10] Proceedings of the International Consensus on Periprosthetic Joint Infection. The Bone & Joint Journal. 2013. DOI: 10.1302/0301-620x.95b11.33135

[11] Global Perspectives on the Management of Periprosthetic Joint Infection. Journal of Bone and Joint Surgery. 2025. DOI: 10.2106/jbjs.25.00775

[12] Higher failure rate of two-stage revision for infected knee arthroplasties in significantly compromised (host-C) patients. Knee Surgery, Sports Traumatology, Arthroscopy. 2018. DOI: 10.1007/s00167-018-5051-y

[13] Polymicrobial Periprosthetic Joint Infections: Outcome of Treatment and Identification of Risk Factors. Journal of Bone and Joint Surgery. 2016. DOI: 10.2106/jbjs.15.01450

[14] Risk of Periprosthetic Joint Infection in Patients With Multiple Arthroplasties. The Journal of Arthroplasty. 2018. DOI: 10.1016/j.arth.2017.10.024

[15] Use of Static or Articulating Spacers for Infection Following Total Knee Arthroplasty. Journal of Bone and Joint Surgery. 2013. DOI: 10.2106/jbjs.l.01461

[16] Traditional Laboratory Markers Hold Low Diagnostic Utility for Immunosuppressed Patients With Periprosthetic Joint Infections. The Journal of Arthroplasty. 2019. DOI: 10.1016/j.arth.2019.03.013

[17] Prosthetic Knee Joint Infection Caused by Mycobacterium kansasii. JAAOS: Global Research and Reviews. 2022. DOI: 10.5435/jaaosglobal-d-21-00183

[18] AAOS Clinical Practice Guideline: Diagnosis and Treatment of Periprosthetic Joint Infections of the Hip and Knee. American Academy of Orthopaedic Surgeon. 2010. DOI: 10.5435/00124635-201012000-00007

[19] Treatment and Outcome of Periprosthetic Joint Infection in Unicompartmental Knee Arthroplasty. The Journal of Arthroplasty. 2020. DOI: 10.1016/j.arth.2020.02.036

[20] A 10-Year Systematic Review of Brucella Periprosthetic Joint Infections Following Total Knee Arthroplasty. JBJS Reviews. 2025. DOI: 10.2106/jbjs.rvw.25.00079

[21] Novel Developments in the Prevention, Diagnosis, and Treatment of Periprosthetic Joint Infections. Journal of the American Academy of Orthopaedic Surgeons. 2015. DOI: 10.5435/jaaos-d-14-00455

[22] Short‐interval two‐stage approach to primary total knee arthroplasty for acutely septic osteoarthritic knees. Knee Surgery, Sports Traumatology, Arthroscopy. 2016. DOI: 10.1007/s00167-016-3982-8

[23] Descriptive Analysis of the Economic Costs of Periprosthetic Joint Infection of the Knee for the Public Health System of Andalusia. The Journal of Arthroplasty. 2013. DOI: 10.1016/j.arth.2013.02.012

[24] The role of synovial fluid analysis in the detection of periprosthetic hip and knee infections: a systematic review and meta-analysis. International Orthopaedics. 2018. DOI: 10.1007/s00264-018-3865-3

[25] Irrigation and Débridement and Prosthesis Retention for Treating Acute Periprosthetic Infections. Clinical Orthopaedics & Related Research. 2010. DOI: 10.1007/s11999-010-1291-y

[26] Routine Use of Antibiotic Laden Bone Cement for Primary Total Knee Arthroplasty: Impact on Infecting Microbial Patterns and Resistance Profiles. The Journal of Arthroplasty. 2014. DOI: 10.1016/j.arth.2013.12.004

[27] Polymicrobial Prosthetic Joint Infections: Risk Factors and Outcome. Clinical Orthopaedics & Related Research. 2008. DOI: 10.1007/s11999-008-0230-7

[28] Success of Debridement, Antibiotics, and Implant Retention in Prosthetic Joint Infection Following Primary Total Knee Arthroplasty: Results From a Prospective Multicenter Study of 189 Cases. The Journal of Arthroplasty. 2023. DOI: 10.1016/j.arth.2023.04.024

[29] What Is the Mid-term Survivorship of Infected Rotating-hinge Implants Treated with One-stage-exchange?. Clinical Orthopaedics & Related Research. 2021. DOI: 10.1097/corr.0000000000001868

[31] New diagnostic tools for prosthetic joint infection. Orthopaedics & Traumatology: Surgery & Research. 2019. DOI: 10.1016/j.otsr.2018.04.029

[34] Multiple Periprosthetic Joint Infections: Evidence for Decreasing Prevalence. The Journal of Arthroplasty. 2016. DOI: 10.1016/j.arth.2016.05.013

[35] The Fate of Acute Methicillin-Resistant Staphylococcus aureus Periprosthetic Knee Infections Treated by Open Debridement and Retention of Components. The Journal of Arthroplasty. 2009. DOI: 10.1016/j.arth.2009.04.028

[36] Oral Therapy, Microbiological Findings, and Comorbidity Influence the Outcome of Prosthetic Joint Infections Undergoing 2-Stage Exchange. The Journal of Arthroplasty. 2017. DOI: 10.1016/j.arth.2017.02.057

[37] A modified Delphi consensus on periprosthetic infection in orthopaedic oncology. The Bone & Joint Journal. 2025. DOI: 10.1302/0301-620x.107b12.bjj-2024-1039.r4

[38] A Permanent Articulating Spacer Versus Two-Stage Exchange for Chronic Periprosthetic Joint Infection: A Propensity Score-Matched Study. The Journal of Arthroplasty. 2023. DOI: 10.1016/j.arth.2023.01.036

[39] Greater Knee Soft Tissue Thickness Predisposes Patients to Subsequent Periprosthetic Joint Infection After Total Knee Arthroplasty. The Journal of Arthroplasty. 2020. DOI: 10.1016/j.arth.2020.02.049

[40] A Lange Medical Book Current Diagnosis Treatment In Orthopedics Fifth Edition. 3Sports Medicine > Image KNEE INJURIES.

[42] Aaos Comprehensive Orthopaedic Review 3. Radiographic Evaluation and Surgical Anatomy of the Knee > I. Radiographic Evaluation.

[43] Determining False Positive Rates of Leukocyte Esterase Reagent Strip When Used as a Detection Tool for Joint Infection. The Journal of Arthroplasty. 2017. DOI: 10.1016/j.arth.2016.05.065

[45] Seronegative infections in hip and knee arthroplasty. The Bone & Joint Journal. 2015. DOI: 10.1302/0301-620x.97b7.35500

[48] A Two-stage Retention Débridement Protocol for Acute Periprosthetic Joint Infections. Clinical Orthopaedics & Related Research. 2010. DOI: 10.1007/s11999-010-1293-9

[50] Clinical outcomes after revision knee arthroplasty due to periprosthetic joint infection: A single‐centre study of 359 knees at a high‐volume centre with a minimum of one year follow‐up. Knee Surgery, Sports Traumatology, Arthroscopy. 2025. DOI: 10.1002/ksa.12762

[51] Two‐stage revision of septic knee prosthesis with articulating knee spacers yields better infection eradication rate than one‐stage or two‐stage revision with static spacers. Knee Surgery, Sports Traumatology, Arthroscopy. 2012. DOI: 10.1007/s00167-012-1885-x

[52] Synovial Fluid MicroRNA Biomarkers Enable Accurate Diagnosis of Hip and Knee Periprosthetic Joint Infections. Journal of Bone and Joint Surgery. 2025. DOI: 10.2106/jbjs.24.01559

[53] Serum and Synovial Markers in the Diagnosis of Periprosthetic Joint Infection of the Hip, Knee, and Shoulder: An Algorithmic Approach. Journal of Bone and Joint Surgery. 2024. DOI: 10.2106/jbjs.23.00669

[54] Multiple Irrigation and Debridements for Periprosthetic Joint Infections: Facing a Necessity or Just Prolonging the Inevitable?. The Journal of Arthroplasty. 2016. DOI: 10.1016/j.arth.2015.06.051

[55] Variation in Inflammatory Biomarkers Among Demographic Groups Significantly Affects Their Accuracy in Diagnosing Periprosthetic Joint Infection. The Journal of Arthroplasty. 2021. DOI: 10.1016/j.arth.2020.10.036

[56] Interleukin-6 in Serum and in Synovial Fluid Enhances the Differentiation between Periprosthetic Joint Infection and Aseptic Loosening. PLoS ONE. 2014. DOI: 10.1371/journal.pone.0089045

[57] The routine use of synovial alpha-defensin is not necessary.. The bone & joint journal. 2020. DOI: 10.1302/0301-620X.102B5.BJJ-2019-0473.R3

[58] Primary Total Knee Arthroplasty in Patients With Neuropathic (Charcot) Arthropathy: Contemporary Results. The Journal of Arthroplasty. 2018. DOI: 10.1016/j.arth.2018.04.003

[59] Conventional Diagnostic Challenges in Periprosthetic Joint Infection. Journal of the American Academy of Orthopaedic Surgeons. 2015. DOI: 10.5435/jaaos-d-14-00385

[60] Diagnosing Periprosthetic Joint Infection: And the Winner Is?. The Journal of Arthroplasty. 2017. DOI: 10.1016/j.arth.2017.06.005

[61] Recurrent Periprosthetic Joint Infection After Irrigation and Debridement With Component Retention Is Most Often Due to Identical Organisms. The Journal of Arthroplasty. 2016. DOI: 10.1016/j.arth.2016.05.040

[62] The Kidney, Liver, Index surgery and C reactive protein score is a predictor of treatment response in acute prosthetic joint infection. International Orthopaedics. 2017. DOI: 10.1007/s00264-017-3670-4

[63] Microbiological pathogen analysis in native versus periprosthetic joint infections: a retrospective study. Journal of Orthopaedic Surgery and Research. 2022. DOI: 10.1186/s13018-021-02850-3

[65] Asymptomatic Elevated Inflammatory Markers: Is There a Risk for Infection or Revision in Primary Total Knee Arthroplasty?. The Journal of Arthroplasty. 2025. DOI: 10.1016/j.arth.2024.10.063

[66] Acceptable Success Rate in Patients With Periprosthetic Knee Joint Infection Treated With Debridement, Antibiotics, and Implant Retention. The Journal of Arthroplasty. 2019. DOI: 10.1016/j.arth.2018.09.088

[68] Periprosthetic Joint Infection: Are Patients Still Better off Than if Primary Arthroplasty Had Not Been Performed?. The Journal of Arthroplasty. 2025. DOI: 10.1016/j.arth.2025.02.011

[69] Clinical Outcome of Massive Endoprostheses Used for Managing Periprosthetic Joint Infections of the Hip and Knee. The Journal of Arthroplasty. 2018. DOI: 10.1016/j.arth.2017.09.046

[70] Wound Complications after Total Knee Arthroplasty. The Journal of Arthroplasty. 2007. DOI: 10.1016/j.arth.2007.03.014

[71] Diagnosis of Periprosthetic Joint Infection: The Threshold for Serological Markers. Clinical Orthopaedics & Related Research. 2013. DOI: 10.1007/s11999-013-3070-z

[72] Treatment of Prosthetic Joint Infection: Established Patient Relationships May Impact Medical Decision-Making. The Journal of Arthroplasty. 2019. DOI: 10.1016/j.arth.2018.09.091

[73] Multidrug-Resistant Organisms in the Setting of Periprosthetic Joint Infection—Diagnosis, Prevention, and Treatment. The Journal of Arthroplasty. 2018. DOI: 10.1016/j.arth.2017.07.045

[74] Failed 2-Stage Revision Knee Arthroplasty for Periprosthetic Joint Infection—Patient Characteristics and Outcomes. The Journal of Arthroplasty. 2023. DOI: 10.1016/j.arth.2023.04.063

[75] Analysis of Synovial Fluid Aspirations in Aseptic Loosening and Instability After Total Knee Arthroplasty. The Journal of Arthroplasty. 2025. DOI: 10.1016/j.arth.2024.12.017

[76] Acceptable mid- to long-term survival rates and functional outcomes following a single design rotating hinge total knee arthroplasty. Knee Surgery, Sports Traumatology, Arthroscopy. 2019. DOI: 10.1007/s00167-019-05593-1

[77] Two-stage Exchange Knee Arthroplasty: Does Resistance of the Infecting Organism Influence the Outcome?. Clinical Orthopaedics & Related Research. 2010. DOI: 10.1007/s11999-010-1296-6

[78] Evaluation of Preoperative Cultures Before Second-Stage Reimplantation of a Total Knee Prosthesis Complicated by Infection. The Journal of Bone and Joint Surgery-American Volume. 2000. DOI: 10.2106/00004623-200011000-00006

[79] The Change of Serum Interleukin-6 Fails to Identify Subsequent Periprosthetic Joint Infection in Patients Who Have Two-Stage Revision for Periprosthetic Joint Infection. The Journal of Arthroplasty. 2023. DOI: 10.1016/j.arth.2023.06.008

[80] Aaos Comprehensive Orthopaedic Review 3. Anatomy and Biomechanics of the Knee > I. Anatomy.

[81] Miller S Review Of Orthopaedics. SECTION 16 PATELLAR TRACKING IN TOTAL KNEE ARTHROPLASTY > SECTION 1 KNEE > ANATOMY (FIG. 4.1).

[82] Miller S Review Of Orthopaedics. SECTION 1 KNEE > ANATOMY (FIG. 4.1).

[85] Aaos Comprehensive Orthopaedic Review 3. Radiographic Evaluation and Surgical Anatomy of the Knee > II. Surgical Anatomy of the Knee.

[90] Aaos Comprehensive Orthopaedic Review 3. Knee Dislocations and Patellar Fractures* > I. Knee Dislocations.

[93] Rockwood And Green S Fractures In Adults. 59: Patellar Fractures and Dislocations and Extensor Mechanism Injuries > Posterior Knee Anatomy.

[97] Aaos Comprehensive Orthopaedic Review 3. Biomechanics and Wear in Joint Arthroplasty > III. The Knee Joint.

[98] Orthopaedic Knowledge Update 13 Ebook Without Multimedia. Knee Anatomy > Knee Kinematics.

[112] Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial. Journal of Orthopaedic Surgery and Research. 2020. DOI: 10.1186/s13018-020-01877-2

[113] Debridement, antibiotics, and implant retention (DAIR) for the early prosthetic joint infection of total knee and hip arthroplasties: a systematic review. Journal of ISAKOS. 2024. DOI: 10.1016/j.jisako.2023.09.003

[114] Irrigation and Debridement in the Management of Prosthetic Joint Infection: Traditional Indications Revisited. The Journal of Arthroplasty. 2010. DOI: 10.1016/j.arth.2010.01.104

[116] Treatment of Infected Total Knee Arthroplasty Using an Articulating Spacer. Clinical Orthopaedics & Related Research. 2005. DOI: 10.1097/01.blo.0000149241.77924.01

[117] Synovial Fluid Alpha-Defensin Is an Adjunctive Tool in the Equivocal Diagnosis of Periprosthetic Joint Infection. The Journal of Arthroplasty. 2018. DOI: 10.1016/j.arth.2018.06.026

[119] The Role of Long-Term Antibiotic Suppression in the Management of Peri-Prosthetic Joint Infections Treated With Debridement, Antibiotics, and Implant Retention: A Systematic Review. The Journal of Arthroplasty. 2020. DOI: 10.1016/j.arth.2019.11.026

[120] The Practice Patterns of American Association of Hip and Knee Surgeons for the Management of Chronic Periprosthetic Joint Infection After Total Knee Arthroplasty. The Journal of Arthroplasty. 2023. DOI: 10.1016/j.arth.2023.04.059

[121] Does Performance of D-Dimer for Diagnosis of Periprosthetic Joint Infection Change With the Virulence of Infecting Organism?. The Journal of Arthroplasty. 2023. DOI: 10.1016/j.arth.2023.05.022

[122] Premature Therapeutic Antimicrobial Treatments Can Compromise the Diagnosis of Late Periprosthetic Joint Infection. Clinical Orthopaedics & Related Research. 2015. DOI: 10.1007/s11999-015-4142-z

[124] Can next generation sequencing play a role in detecting pathogens in synovial fluid?. The Bone & Joint Journal. 2018. DOI: 10.1302/0301-620x.100b2.bjj-2017-0531.r2

[127] Systemic Safety of High-Dose Antibiotic-Loaded Cement Spacers after Resection of an Infected Total Knee Arthroplasty. Clinical Orthopaedics and Related Research. 2004. DOI: 10.1097/01.blo.0000144476.43661.10

[128] Is it Time to Include Vancomycin for Routine Perioperative Antibiotic Prophylaxis in Total Joint Arthroplasty Patients?. The Journal of Arthroplasty. 2012. DOI: 10.1016/j.arth.2012.03.040

[130] Can a Silver-Coated Arthrodesis Implant Provide a Viable Alternative to Above Knee Amputation in the Unsalvageable, Infected Total Knee Arthroplasty?. The Journal of Arthroplasty. 2016. DOI: 10.1016/j.arth.2016.04.009

[133] Concomitant Multiple Joint Arthroplasty Infections: Report on 16 Cases. The Journal of Arthroplasty. 2016. DOI: 10.1016/j.arth.2016.02.012

[138] No effect of vancomycin powder to prevent infection in primary total knee arthroplasty: a retrospective review of 976 cases. Knee Surgery, Sports Traumatology, Arthroscopy. 2019. DOI: 10.1007/s00167-019-05778-8

[139] Is Topical Vancomycin an Option? A Randomized Controlled Trial to Determine the Safety of the Topical Use of Vancomycin Powder in Preventing Postoperative Infections in Total Knee Arthroplasty, as Compared With Standard Postoperative Antibiotics. The Journal of Arthroplasty. 2023. DOI: 10.1016/j.arth.2023.01.040

[140] Repeat Two-Stage Exchange Arthroplasty for Recurrent Periprosthetic Knee Infection: Results of 87 Cases. The Journal of Arthroplasty. 2025. DOI: 10.1016/j.arth.2025.03.005

[142] External Validation of the Joint-Specific Bone Involvement, Antimicrobial Options, Coverage of the Soft Tissues, and Host Status (JS-BACH) Classification for Predicting Outcome in Periprosthetic Joint Infections: A Cohort of 653 Patients. The Journal of Arthroplasty. 2024. DOI: 10.1016/j.arth.2024.03.070

[143] Modern Treatment of Infected Total Knee Arthroplasty With a 2-Stage Reimplantation Protocol. The Journal of Arthroplasty. 2010. DOI: 10.1016/j.arth.2009.07.017

[145] Infection Control Rate of Irrigation and Débridement for Periprosthetic Joint Infection. Clinical Orthopaedics & Related Research. 2011. DOI: 10.1007/s11999-011-1910-2

[146] A comparsion study between debridement, antibiotics, and implant retention and two-stage revision total knee arthroplasty for the management of periprosthetic joint infection occurring within 12 weeks from index total knee arthroplasty. Journal of Orthopaedic Surgery and Research. 2022. DOI: 10.1186/s13018-022-03218-x

[147] Septic arthritis of the knee joint secondary to adjacent chronic osteomyelitis of the femur in an adult. Knee Surgery, Sports Traumatology, Arthroscopy. 2009. DOI: 10.1007/s00167-009-0976-9

[148] Risk Factors for Repeat Debridement, Spacer Retention, Amputation, Arthrodesis, and Mortality After Removal of an Infected Total Knee Arthroplasty With Spacer Placement. The Journal of Arthroplasty. 2018. DOI: 10.1016/j.arth.2017.08.037

[149] Comparison of Risk Factors for 1- and 2-Stage Revisions for Chronic Knee Periprosthetic Joint Infections. The Journal of Arthroplasty. 2025. DOI: 10.1016/j.arth.2025.05.127

[152] Intrawound vancomycin powder increases post-operative wound complications and does not decrease periprosthetic joint infection in primary total and unicompartmental knee arthroplasties. Knee Surgery, Sports Traumatology, Arthroscopy. 2019. DOI: 10.1007/s00167-019-05498-z

[155] An Articulating Spacer to Treat and Mobilize Patients with Infected Total Knee Arthroplasty. The Journal of Arthroplasty. 2009. DOI: 10.1016/j.arth.2008.04.003

[157] Development and Validation of an Evidence-Based Algorithm for Diagnosing Periprosthetic Joint Infection. The Journal of Arthroplasty. 2019. DOI: 10.1016/j.arth.2019.06.016

[159] CORR Insights®: Neutrophil Extracellular Trap-related Biomarkers Are Increased in the Synovial Fluid of Patients With Periprosthetic Joint Infections. Clinical Orthopaedics & Related Research. 2024. DOI: 10.1097/corr.0000000000002971

[161] How Reliable Is the Cell Count Analysis in the Diagnosis of Prosthetic Joint Infection?. The Journal of Arthroplasty. 2018. DOI: 10.1016/j.arth.2018.05.018

[162] Prior Cellulitis as a Risk Factor for Periprosthetic Joint Infection in Total Knee Arthroplasty: Influence of Timing and Antibiotic Prophylaxis. The Journal of Arthroplasty. 2026. DOI: 10.1016/j.arth.2025.07.007

[165] Clinical Evaluation of Alpha Defensin Test Following Staged Treatment of Prosthetic Joint Infections. The Journal of Arthroplasty. 2019. DOI: 10.1016/j.arth.2019.03.019

[166] Is Single-stage Revision According to a Strict Protocol Effective in Treatment of Chronic Knee Arthroplasty Infections?. Clinical Orthopaedics & Related Research. 2015. DOI: 10.1007/s11999-014-3721-8

[167] Diagnosing Prosthetic Joint Infections in Patients With Inflammatory Arthritis: A Systematic Literature Review. The Journal of Arthroplasty. 2019. DOI: 10.1016/j.arth.2019.01.051

[169] An often-unrecognized entity as cause of recurrent infection after successfully treated two-stage exchange arthroplasty: hematogenous infection. Archives of Orthopaedic and Trauma Surgery. 2018. DOI: 10.1007/s00402-018-2972-3

[171] Staged revision for knee arthroplasty infection: what is the role of serological tests prior to reimplantation?. The Journal of Arthroplasty. 2009. DOI: 10.1016/j.arth.2008.11.041

[172] The Impact of Patient and Surgical Factors for Primary Knee Arthroplasty Infection. Orthopaedic Journal of Sports Medicine. 2016. DOI: 10.1177/2325967116s00087

[173] Diagnostic accuracy of intra-articular C-reactive protein assay in periprosthetic knee joint infection – a preliminary study. Orthopaedics & Traumatology: Surgery & Research. 2014. DOI: 10.1016/j.otsr.2013.10.017

[174] What Is the Role of Diagnostic and Therapeutic Sonication in Periprosthetic Joint Infections?. The Journal of Arthroplasty. 2018. DOI: 10.1016/j.arth.2018.02.077

[176] What Is the Incidence of and Outcomes After Debridement, Antibiotics, and Implant Retention (DAIR) for the Treatment of Periprosthetic Joint Infections in the AJRR Population?. Clinical Orthopaedics & Related Research. 2024. DOI: 10.1097/corr.0000000000003138

[190] The AAHKS Surgical Techniques and Technologies Award: Synovial Fluid Metal Ion Levels as a Biomarker for Aseptic Loosening Following Cemented Total Knee Arthroplasty: A Prospective Study. The Journal of Arthroplasty. 2025. DOI: 10.1016/j.arth.2025.04.067

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International


Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees


Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.


Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.